Vaxart (VXRT) Tmuɣli n wazal
Vaxart
Ṛṛbem n lḥedd$0.45Yettwalemmaḍ 25 Sep 2026
Beddel0.00%
Asnulfu n AI: VXRT
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Vaxart, Inc. is a biotechnology company that develops and commercializes oral influenza vaccines. These vaccines activate the immune system in the gut and stimulate the production of systemic and mucosal immune responses. The company provides services to clients worldwide.
